Market Outlook

By 2035, the U.S. Orthopedic Devices Market is expected to reach approximately USD 56.35 billion, expanding at an estimated CAGR of 5.56% during the forecast period 2026–2035. The market is estimated at USD 32.80 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions. The market model is positioned within the range of recent industry estimates, including a U.S. orthopedic devices estimate of USD 30.6 billion for 2025 and another industry assessment placing the U.S. market at approximately USD 34.5 billion in 2026.

The U.S. orthopedic devices industry is one of the largest and most procedure-intensive segments of the medical technology market. Demand is supported by osteoarthritis, osteoporosis, degenerative spine disease, trauma, sports injuries, age-related joint deterioration, obesity-associated musculoskeletal disease, and increasing expectations for maintaining mobility later in life. Approximately 53 million U.S. adults have diagnosed arthritis, while arthritis prevalence rises sharply with age and exceeds 50% among adults aged 75 and older. At the same time, the U.S. population aged 65 and above reached approximately 61.2 million in 2024, representing 18% of the population and creating a structurally expanding patient pool for joint replacement, fracture fixation, spine surgery, extremity reconstruction, and mobility-restoring procedures.

The industry is moving beyond conventional implant competition toward integrated orthopedic procedure platforms that combine implants, robotic assistance, navigation, preoperative planning, intraoperative data, personalized instrumentation, advanced biomaterials, 3D printing, and post-surgical analytics. Procurement decisions at leading U.S. hospitals increasingly consider total episode economics rather than implant price alone. Technologies that reduce operating-room variability, shorten procedural setup, improve implant positioning, lower revision exposure, enable same-day discharge, and support migration of procedures toward ambulatory surgery centers are becoming strategically important.

The historical market is estimated to have expanded from approximately USD 26.40 billion in 2021 to USD 31.10 billion in 2024, supported by normalization of elective surgical volumes after the pandemic, recovery in joint reconstruction procedures, rising adoption of cementless knees and hips, expanding spine intervention, trauma demand, and investment in robotic-assisted orthopedic surgery. The market reached approximately USD 32.80 billion in 2025 as procedure volumes remained resilient and orthopedic manufacturers intensified competition around enabling technologies, outpatient-compatible platforms, shoulder reconstruction, extremities, biologics, and personalized joint replacement.

Long-term growth is not expected to come from implant volume alone. The highest-value opportunity will increasingly be created around the implant: patient-specific planning, robotics, navigation, software, disposable instrumentation, revision solutions, biologic augmentation, and connected surgical workflow. This shift is changing both manufacturer strategy and hospital procurement behavior.

 

Introduction

According to the U.S. Orthopedic Devices Market Report, orthopedic care in the United States is supported by one of the world’s most developed networks of orthopedic surgeons, academic hospitals, community health systems, ambulatory surgery centers, trauma centers, sports medicine practices, and specialty musculoskeletal facilities. The market encompasses joint reconstruction implants, spine systems, trauma fixation, sports medicine products, arthroscopy systems, orthobiologics, extremity devices, surgical instruments, robotic platforms, navigation systems, and related enabling technologies.

The clinical foundation of the market is exceptionally large. Diagnosed arthritis affects more than 53 million U.S. adults, and approximately 88% of adults with arthritis are aged 45 years or older. Osteoporosis creates another substantial device-relevant population: approximately 10 million Americans have osteoporosis and another 44 million have low bone mass, contributing to an estimated two million osteoporosis-related fractures annually. Older-adult falls add further trauma demand, with more than 14 million Americans aged 65 and older reporting a fall each year and an estimated nine million experiencing an injury requiring medical treatment or activity restriction.

The orthopedic devices market also benefits from a large recurring surgical base. The American Joint Replacement Registry alone had captured more than four million hip and knee arthroplasty procedures by 2024, while its 2025 report analyzed more than 4.4 million procedures collected through 2024. The broader registry program surpassed 4.5 million procedures across multiple orthopedic registries. These figures illustrate the scale of U.S. joint reconstruction and the importance of registry evidence in implant selection, clinical benchmarking, revision analysis, and value-based procurement.

Orthopedic demand is also linked to obesity. More than 40% of U.S. adults were classified as having obesity during the 2021–2023 measurement period, while severe obesity approached 10%. Excess body weight increases mechanical loading across weight-bearing joints and complicates both non-operative musculoskeletal management and surgical care. This creates a large clinical intersection between obesity, osteoarthritis, lower-extremity joint degeneration, mobility impairment, and eventual reconstructive surgery.

From a healthcare economics perspective, orthopedics occupies an unusual position. Many procedures are high-value, scheduled interventions that can generate attractive contribution margins for health systems, but hospitals simultaneously face aggressive pressure to reduce implant costs, standardize vendors, improve operating-room turnover, shorten length of stay, and move appropriate procedures to lower-cost settings. CMS payment policies affect thousands of hospitals and approximately 6,000 ambulatory surgery centers, making site-of-care economics increasingly relevant to orthopedic device commercialization.

The strategic direction of the market through 2035 will therefore be shaped by the convergence of implant innovation, enabling technology, outpatient surgery, evidence-based procurement, and procedure standardization. Manufacturers able to demonstrate economic value at the entire episode-of-care level will have an advantage over suppliers competing primarily through implant design or surgeon preference.

 

Key Market Drivers: What’s Fueling the U.S. Orthopedic Devices Market Boom?

The first major driver is the expanding population living with degenerative musculoskeletal disease. Arthritis affects roughly one in five U.S. adults, and prevalence increases materially among older populations. Osteoarthritis is particularly important for orthopedic device demand because advanced disease of the knee, hip, shoulder, and other joints can eventually progress toward surgical reconstruction after conservative therapies no longer adequately control pain or functional limitation. The aging of the U.S. population makes this a durable rather than temporary growth factor.

A second driver is demographic aging itself. Approximately 61.2 million Americans were aged 65 or older in 2024, up 13% from 2020. Older adults represented 18% of the U.S. population, compared with 12.4% two decades earlier. Orthopedic procedure utilization rises substantially with age because degenerative joint disease, spinal stenosis, fragility fractures, rotator cuff pathology, and mobility-limiting musculoskeletal conditions accumulate over time.

A third driver is sustained joint replacement demand. Hip and knee arthroplasty have become highly standardized procedures supported by mature implant technologies, improved perioperative protocols, enhanced recovery programs, and increasing patient acceptance. U.S. hip replacement volumes alone have been projected to approach approximately 850,000 procedures annually by 2030 under published procedure projections. Large procedure volumes also create an expanding future revision market because more implants placed today ultimately create a larger installed base requiring management over subsequent decades.

A fourth driver is the continuing migration of appropriate orthopedic procedures toward outpatient hospitals and ambulatory surgery centers. Total joint replacement, arthroscopy, sports medicine, hand procedures, foot and ankle surgery, and selected spine procedures increasingly fit shorter-stay models when patient selection is appropriate. This transition changes device economics. ASCs typically have greater sensitivity to inventory, capital expenditure, instrument processing, operating-room footprint, staffing, and procedure time than large tertiary hospitals. Manufacturers are therefore redesigning orthopedic platforms around smaller footprints, efficient sterile processing, streamlined trays, portable navigation, handheld robotics, and predictable disposable costs.

A fifth driver is orthopedic robotics and digital surgery. Robotic assistance has moved from an emerging differentiator to a central competitive battleground in joint replacement and increasingly in spine and shoulder surgery. Stryker reported more than 1.5 million Mako procedures across 45 countries by early 2025 and more than 2.5 million procedures across 47 countries by July 2026. Zimmer Biomet has expanded the ROSA platform, while DePuy Synthes continues building the VELYS ecosystem across knee, hip, and spine applications.

A sixth driver is the burden of fractures and trauma. Approximately two million osteoporosis-associated broken bones occur annually in the United States, while older-adult falls remain one of the country’s largest injury sources. Trauma fixation therefore provides recurring demand for plates, screws, nails, external fixation systems, intramedullary devices, fracture-specific implants, bone substitutes, and extremity reconstruction technologies.

A seventh driver is the expanding spine surgery population. Lumbar spinal stenosis is strongly age-associated and remains a major surgical indication in older adults. Published clinical literature estimates that approximately 600,000 procedures are performed annually in the United States for lumbar spinal stenosis, demonstrating the scale of the addressable spine intervention ecosystem. Demand spans pedicle screw systems, interbody cages, cervical devices, navigation, robotics, biologics, minimally invasive instruments, expandable cages, and sacroiliac fixation.

Finally, hospital purchasing behavior is becoming more sophisticated. Large integrated delivery networks increasingly consolidate implant contracts across facilities, limit surgeon-specific vendor variation, negotiate bundled pricing, and assess technologies through value analysis committees. Manufacturers must therefore defend premium technologies using clinical outcomes, workflow efficiency, revision economics, inventory reduction, and surgeon recruitment benefits. An implant that costs more can still win if it measurably improves the overall economics of the episode.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Orthopedic innovation is moving from mechanical replacement toward data-enabled reconstruction. Historically, differentiation centered on implant geometry, metallurgy, polyethylene, fixation, and instrument design. Those attributes remain important, but future competition will increasingly occur across the combined implant-and-technology ecosystem.

Robotics is the most visible expression of this transformation. Stryker’s Mako platform now spans hip, knee, spine, and shoulder applications, while the fourth-generation Mako system integrates broader guidance capabilities. In July 2026, the company launched the Mako RPS handheld robotic system for total knee replacement, extending robotic assistance into a smaller, power-tool-oriented format intended to reach additional customer segments and care settings.

Zimmer Biomet is pursuing a different robotics expansion strategy. The company completed its acquisition of Monogram Technologies in October 2025, adding semi-autonomous and developing fully autonomous orthopedic robotic capabilities to a portfolio already centered on ROSA. Monogram’s CT-based semi-autonomous total knee system had received FDA clearance earlier in 2025. Zimmer Biomet subsequently received FDA clearance for an enhanced ROSA Knee platform and continued expansion of ROSA Shoulder.

DePuy Synthes is increasingly positioning VELYS as an enabling-technology ecosystem rather than a single knee robot. In June 2026, it introduced U.S. commercial availability of AI-assisted VELYS Hip Navigation. The system automates aspects of image interpretation and landmark identification to support real-time assessment of leg length, offset, and cup positioning. The company also launched an active robotic and navigation platform for spine surgery and is pursuing miniature radiofrequency tracking technologies intended to reduce dependence on conventional line-of-sight optical tracking.

Personalized orthopedic planning represents another major innovation cycle. CT-based and imageless planning systems can help surgeons model implant size, orientation, alignment, bone resection, deformity correction, and soft-tissue balance before or during surgery. Over time, machine learning will increasingly support procedural planning and intraoperative decision assistance. The commercial value is not simply greater precision; it is the potential to reduce variation between surgeons, simplify complex cases, and create reproducible workflows across hospital networks.

Cementless fixation is also gaining strategic relevance in joint reconstruction. As younger and more active patients enter the arthroplasty population, manufacturers are increasing investment in porous metals, advanced coatings, additive manufacturing, and biologic fixation surfaces intended to support bone ingrowth. Cementless knee adoption is particularly important because it can expand premium implant opportunities within an otherwise mature total knee market.

Three-dimensional printing is reshaping spine, revision arthroplasty, trauma, and complex reconstruction. Additive manufacturing enables porous structures that are difficult to produce through conventional machining and supports patient-specific components for unusual anatomy or severe bone loss. In spine, 3D-printed interbody cages have become increasingly common, while complex acetabular reconstruction and tumor surgery provide additional opportunities for personalized implants.

Orthobiologics represent another innovation layer. Bone graft substitutes, demineralized bone matrices, cellular products, synthetic graft materials, bone morphogenetic technologies, and regenerative solutions are used to support fusion or healing in selected orthopedic procedures. Commercial success increasingly depends on evidence, surgeon confidence, handling characteristics, storage requirements, and reimbursement rather than biologic novelty alone.

Implant companies are also reducing instrumentation complexity. Traditional joint and spine procedures can require numerous trays, creating sterilization expense, storage needs, setup time, and operating-room logistics. Streamlined instrumentation, single-use components, procedure-specific kits, and digitally guided workflows can lower the operational burden associated with orthopedic cases. This is especially valuable in ASCs, where every additional tray and processing cycle affects economics.

The next innovation frontier will therefore be defined less by individual products and more by platform orchestration: preoperative imaging, AI-supported planning, implants, robotic execution, navigation, intraoperative analytics, instrument management, and postoperative outcome data operating as a connected surgical system.

 

Segmentation Insights

The U.S. Orthopedic Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

• Joint reconstruction devices represent the largest value pool within the U.S. orthopedic devices market. The category includes total and partial knee implants, hip systems, shoulder arthroplasty, revision implants, bearing surfaces, fixation components, and associated instrumentation. Knee and hip replacement account for the largest established revenue base, while shoulder replacement is increasingly attractive because of expanding surgeon adoption, reverse shoulder procedures, and robotic planning. Implant manufacturers are competing through cementless fixation, advanced porous surfaces, personalized alignment philosophies, robotic compatibility, and revision-system breadth.
• Spinal devices form another major segment and include pedicle screw systems, rods, interbody cages, cervical plates, disc replacement technologies, expandable cages, minimally invasive instrumentation, sacroiliac fixation, biologics, and navigation-compatible implants. Spine remains clinically complex and commercially fragmented. Growth is increasingly directed toward minimally invasive surgery, lateral and anterior approaches, expandable interbody technologies, robotic navigation, and integrated biologics. Approximately 600,000 U.S. procedures have been estimated annually for lumbar spinal stenosis alone, underscoring the scale of the addressable patient population.
• Trauma and extremity devices include fracture plates, screws, intramedullary nails, external fixation systems, hand and wrist implants, foot and ankle reconstruction, small-joint implants, and fracture management technologies. The segment benefits from stable emergency-driven demand and growing elective extremity reconstruction. The combination of osteoporosis, older-adult falls, sports injuries, and active aging supports both trauma fixation and secondary reconstructive procedures.
• Sports medicine and arthroscopy devices include suture anchors, interference screws, soft-tissue fixation devices, arthroscopes, shavers, radiofrequency systems, fluid-management systems, meniscal repair products, ligament reconstruction technologies, and shoulder repair products. Knee and shoulder procedures dominate volume, while hip arthroscopy and smaller-joint applications provide additional growth opportunities. Unlike arthroplasty, sports medicine often serves younger and more active patients, giving manufacturers exposure to a different demographic profile.
• Orthobiologics and related regenerative products support fusion, fracture healing, bone defect management, and selected reconstructive procedures. Bone graft substitutes, synthetic materials, demineralized matrices, biologically active products, and bone-growth technologies are increasingly integrated into spine, trauma, and revision surgery. The segment is attractive because biologic products frequently generate recurring procedure-level revenue rather than one-time capital revenue.

 

By Application

• Knee reconstruction is the largest orthopedic application by procedure scale and commercial importance. Advanced osteoarthritis, deformity, post-traumatic degeneration, and failed prior reconstruction drive total knee, partial knee, and revision procedures. Competitive differentiation is increasingly linked to cementless fixation, robotic assistance, personalized alignment, implant kinematics, and reduced instrumentation. Knee reconstruction is also becoming one of the most important battlegrounds for outpatient orthopedic surgery.
• Hip reconstruction represents another high-value application. Primary total hip arthroplasty has benefited from improved implant survivorship, increasing use of anterior approaches, navigation, robotic planning, and dual-mobility technologies. U.S. annual THA volumes have been projected to reach approximately 850,000 procedures around 2030, creating substantial opportunities not only in primary implants but also revision systems and enabling technologies.
• Spine surgery includes degenerative disease, deformity, stenosis, instability, trauma, and other conditions requiring decompression, fusion, fixation, or disc replacement. The commercial opportunity extends beyond implants to imaging, navigation, robotics, biologics, neuromonitoring-compatible instrumentation, and workflow software. Spine is one of the orthopedic categories where enabling technologies can significantly influence surgeon preference and hospital capital purchasing.
• Trauma and fracture management is supported by falls, road injuries, workplace injuries, sports activity, osteoporosis, and other acute events. Fragility fractures are especially important because they combine high clinical burden with the growing older population. Approximately two million osteoporosis-related fractures occur annually in the United States, creating sustained demand across hip fracture fixation, long-bone trauma, wrist fractures, shoulder fractures, and vertebral reconstruction.
• Shoulder, sports medicine, and extremity reconstruction is expanding as orthopedic manufacturers pursue growth outside traditional hip and knee categories. Shoulder arthroplasty, rotator cuff repair, ACL reconstruction, meniscal repair, hand surgery, foot and ankle reconstruction, and soft-tissue procedures offer attractive specialization opportunities. These segments can also be highly compatible with ASC-based care, increasing their strategic importance as site-of-service migration accelerates.

 

By End User

• Hospitals and integrated health systems remain the largest end-user segment. They perform the majority of complex joint revisions, trauma care, major spine procedures, difficult reconstructions, and medically complex orthopedic surgeries. Large health systems also exercise significant purchasing power. Enterprise contracts can cover implants, surgical instruments, biologics, navigation platforms, robotics, maintenance, and disposable products across multiple facilities.
• Value analysis committees increasingly assess more than purchase price. An orthopedic platform may be evaluated according to operating-room time, instrument trays, sterilization burden, revision risk, discharge patterns, implant standardization, training requirements, service quality, and the ability to retain high-volume surgeons. Vendors that can demonstrate cross-facility economic value are better positioned to secure system-level agreements.
• Ambulatory surgery centers represent the fastest-changing end-user group. CMS payment policies affect approximately 6,000 ASCs, while private-payer contracts and patient preference continue supporting orthopedic migration to outpatient settings.
• ASCs are especially important for primary joint replacement in appropriately selected patients, arthroscopy, sports medicine, hand procedures, foot and ankle surgery, and selected spine interventions. These facilities favor technologies that require fewer trays, smaller capital footprints, predictable consumable costs, efficient turnover, and minimal staffing complexity. Portable navigation and handheld robotics could therefore expand more rapidly than large fixed systems in selected ASC environments.
• Orthopedic specialty hospitals and musculoskeletal centers are strategically important because of their concentrated procedure volume. High orthopedic case density creates stronger economics for robotic platforms, dedicated implant inventories, standardized protocols, and advanced perioperative programs. These facilities can also become reference centers that influence surrounding surgeon adoption.
• Orthopedic clinics and physician-owned practices play an important role in diagnosis, conservative management, preoperative selection, follow-up, bracing, biologic procedures, and care coordination. Although their direct implant purchasing is smaller than hospitals and ASCs, these practices influence referral patterns and surgeon preference.
• Trauma centers and academic medical centers remain essential for complex fracture care, deformity correction, revision arthroplasty, spine surgery, clinical trials, resident training, and early adoption of novel technologies. Manufacturers frequently use leading academic centers to generate evidence and develop surgeon advocates before expanding into community practice.

 

By Technology Type

• Conventional implant systems continue to dominate orthopedic device revenue. This group includes metallic and polymer joint implants, spinal fixation systems, trauma hardware, extremity implants, and sports medicine fixation devices. Mature does not mean stagnant: implant design continues evolving through porous structures, alternative bearings, improved coatings, modularity, anatomy-specific geometry, and revision capabilities.
• Robotic-assisted surgery systems are expected to be among the fastest-growing technology categories through 2035. Competition is broadening from large robotic arms to handheld systems, active robotics, navigation-assisted instruments, and eventually higher levels of automation. The strategic value of robotics is also changing. Hospitals increasingly view robots as service-line infrastructure capable of supporting surgeon recruitment, marketing, standardization, case growth, and data collection.
• Navigation and digital surgery technologies include optical tracking, imageless navigation, fluoroscopy-assisted navigation, CT-based planning, AI-supported image interpretation, smart instruments, and intraoperative analytics. These platforms may offer a lower-cost pathway into digital orthopedics for facilities that cannot justify a full robotic system.
• 3D-printed and patient-specific technologies include porous implants, custom components, patient-specific guides, complex revision solutions, spinal cages, and anatomy-matched reconstruction products. Their greatest value is often found in complex cases where standard implants cannot adequately address bone loss or unusual anatomy.
• Advanced biomaterials and biologic technologies include highly cross-linked polyethylene, porous titanium, ceramics, bioactive coatings, bone graft substitutes, synthetic grafts, and regenerative products. Biomaterial innovation is central to improving fixation, wear characteristics, fusion success, and implant longevity, particularly as orthopedic procedures expand among younger and more active patients.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Orthopedic Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs materially according to population size, age distribution, obesity burden, arthritis prevalence, hospital density, orthopedic surgeon concentration, ASC penetration, sports participation, trauma burden, payer mix, and adoption of robotic-assisted surgery.

The South is estimated to represent the largest regional market in 2025 at approximately USD 11.50 billion, followed by the West at USD 8.20 billion, the Northeast at USD 7.20 billion, and the Midwest at USD 5.90 billion. The West is projected to show the strongest percentage expansion through 2035, while the South should remain the largest absolute revenue opportunity.

South

The South includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma. The region combines the country’s largest high-growth population centers with significant arthritis, obesity, trauma, and aging-related orthopedic demand.

Texas is one of the most strategically important state markets. The state’s population exceeded 31.7 million in 2025, making it the second-largest U.S. state by population. Dallas-Fort Worth, Houston, Austin, and San Antonio support major hospital systems, orthopedic groups, trauma facilities, sports medicine practices, and expanding outpatient surgical infrastructure. Rapid population expansion gives Texas an unusual combination of high current procedure volume and attractive long-term growth.

Florida offers a different demand profile. Its population exceeded 23.4 million in 2025, and approximately 22% of residents are aged 65 or older. This demographic structure makes Florida particularly important for knee and hip arthroplasty, shoulder replacement, fragility fracture treatment, spine procedures, and revision surgery. Large retirement populations also support continued expansion of outpatient orthopedic care.

North Carolina and Georgia have become increasingly important due to strong population growth and expansion of major health systems. Tennessee has a large orthopedic and musculoskeletal industry presence and supports significant specialty care in Nashville, Memphis, Knoxville, and surrounding markets. Virginia and Maryland benefit from affluent metropolitan populations, dense healthcare networks, and sophisticated academic and referral centers.

West Virginia, Kentucky, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma present a different opportunity. Musculoskeletal disease burden can be high, while access to advanced orthopedic specialists may be less uniform outside metropolitan centers. Manufacturers that combine referral-center technologies with efficient community-hospital and ASC offerings can address both premium and access-oriented demand.

The Southern market is projected to rise from approximately USD 11.50 billion in 2025 to around USD 20.60 billion by 2035, supported by population growth, aging, obesity-associated joint disease, increasing ASC infrastructure, trauma demand, and adoption of robotic-assisted joint replacement.

West

The West includes California, Washington, Oregon, Nevada, Arizona, Utah, Colorado, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. The region is estimated at approximately USD 8.20 billion in 2025 and is expected to record the strongest regional CAGR through 2035.

California is the largest state orthopedic market in the region and the largest state in the country by population, with approximately 39.4 million residents in 2025. The state has a dense network of academic medical centers, orthopedic specialty providers, large integrated delivery networks, ambulatory centers, sports medicine programs, and digital health companies.

California is especially important for technologies involving robotics, navigation, AI-assisted surgical planning, outpatient joint replacement, sports medicine, and personalized implants. Large healthcare systems can support enterprise technology purchasing, while physician groups and ASCs create demand for smaller-footprint enabling technologies.

Arizona and Nevada are high-growth orthopedic markets because population expansion and retirement migration increase both total procedure demand and the proportion of patients requiring degenerative joint care. Arizona is particularly attractive for arthroplasty, spine care, and outpatient orthopedic surgery.

Colorado and Utah have relatively active populations and sophisticated orthopedic practices, supporting sports medicine, joint preservation, arthroplasty, and spine care. Washington and Oregon have large integrated health systems and strong adoption of evidence-driven clinical pathways.

Idaho, Montana, Wyoming, Alaska, and New Mexico have smaller populations, but geography can increase the strategic importance of regional referral centers. Portable technologies, streamlined instruments, and remote planning capabilities can have meaningful value where specialist access is concentrated.

The West is expected to grow from approximately USD 8.20 billion in 2025 to USD 15.30 billion in 2035, reflecting above-average adoption of enabling technologies, population growth in Mountain West states, outpatient migration, and strong innovation-driven purchasing.

Northeast

The Northeast is estimated at approximately USD 7.20 billion in 2025 and includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine.

New York is the region’s largest state market, supported by a population of approximately 20 million, major academic centers, high procedure density, and extensive hospital infrastructure. Pennsylvania, with more than 13 million residents, supports large orthopedic markets in Philadelphia, Pittsburgh, and regional health networks.

Massachusetts has an outsized influence on orthopedic innovation because of its academic hospitals, biomedical research ecosystem, specialty surgeons, and early adoption of advanced medical technologies. New Jersey combines a large insured population with dense hospital and ambulatory networks.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine are smaller in absolute revenue but contain relatively mature healthcare systems and aging populations. New England markets are particularly relevant for joint replacement, spine, upper-extremity reconstruction, and evidence-driven adoption of new technologies.

Procurement in the Northeast tends to be rigorous. Academic hospitals and large integrated systems often require detailed clinical evidence, health-economic justification, supply-chain reliability, and system-wide contracting before broad adoption. This can slow initial purchasing decisions but create durable positions for vendors that successfully establish enterprise relationships.

The Northeast is projected to reach approximately USD 11.40 billion by 2035. Growth will remain solid but comparatively moderate because of slower population expansion and the maturity of existing orthopedic infrastructure.

Midwest

The Midwest accounted for an estimated USD 5.90 billion in 2025 and includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, and Michigan are the region’s largest patient markets. Their combined population base supports substantial demand for joint reconstruction, spine surgery, trauma fixation, and sports medicine. Chicago provides a major academic and community orthopedic ecosystem, while Cleveland, Columbus, Cincinnati, Detroit, and other metropolitan centers support high-volume referral care.

Minnesota is strategically important beyond its population size because of its medical technology ecosystem and concentration of engineering and manufacturing expertise. Indiana also has unique industry importance because Warsaw and the surrounding region remain deeply associated with the U.S. orthopedic manufacturing cluster.

Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota provide stable procedure demand through community hospitals, regional referral networks, orthopedic practices, and increasingly ambulatory settings. Rural geography creates opportunities for technologies that simplify procedures and reduce dependence on large tertiary infrastructure.

The Midwest is projected to reach approximately USD 9.05 billion by 2035. Growth is expected to trail the South and West but remain durable because of an aging patient base, established orthopedic care networks, trauma demand, and strong manufacturer relationships.

 

Key Market Players

The U.S. Orthopedic Devices Competitive Landscape is moderately consolidated in major joint reconstruction and orthopedic enabling technologies, while remaining fragmented in spine, sports medicine, extremities, orthobiologics, specialized trauma, and emerging digital surgery.

Competition increasingly occurs at the ecosystem level. A hospital choosing a knee implant may also be selecting a robot, instrument platform, service contract, clinical support model, data environment, and long-term vendor relationship. This favors manufacturers that can combine implants with enabling technologies while still providing attractive episode-of-care economics.

Some of the key players in the U.S. Orthopedic Devices industry are:

Stryker Corporation
Zimmer Biomet Holdings
DePuy Synthes
Smith+Nephew
Medtronic
Globus Medical
Enovis Corporation
Arthrex
CONMED Corporation
Integra LifeSciences
Orthofix Medical
B. Braun / Aesculap
MicroPort Orthopedics
Treace Medical Concepts
SI-BONE
THINK Surgical
Exactech
Acumed
Highridge Medical
Life Spine
restor3d
Canary Medical
Bioventus
Anika Therapeutics
OSSIO

Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew form the core competitive group in large-joint reconstruction, with differentiated robotics and enabling-technology strategies. Stryker has built one of the industry’s largest robotics installed ecosystems around Mako. Zimmer Biomet is expanding ROSA while using acquisitions to strengthen robotics, extremities, and specialized reconstruction. DePuy Synthes is broadening VELYS across knee, hip, and spine. Smith+Nephew competes through joint reconstruction, CORI robotics, sports medicine, and advanced wound and biologic technologies.

Medtronic and Globus Medical are major spine competitors with extensive fixation, interbody, navigation, and enabling-technology portfolios. Arthrex has a particularly strong position in sports medicine and soft-tissue repair. Enovis has built scale across reconstructive orthopedics, bracing, foot and ankle, and enabling technologies.

Future market share will be influenced by more than surgeon relationships. FDA clearance cadence, robotics utilization, implant pull-through, hospital contracting, ASC suitability, capital flexibility, instrument efficiency, supply reliability, clinical evidence, revision performance, and digital ecosystem integration will determine competitive strength.

 

Recent Developments

Recent developments show that U.S. orthopedics is entering a new phase of robotics consolidation and platform competition.

In July 2026, Stryker announced full U.S. commercial release of Mako RPS for total knee replacement, introducing a handheld robotic architecture alongside its established robotic-arm platform. The system combines intraoperative planning with robotically enabled cutting technology and is designed to broaden access to robotic knee procedures across additional care settings. Stryker reported that the wider Mako ecosystem had supported more than 2.5 million procedures globally.

In June 2026, DePuy Synthes launched VELYS Hip Navigation with AI Assistance in the United States. The platform automates aspects of landmark identification and image interpretation and provides patient-specific intraoperative information for total hip arthroplasty. This development illustrates how AI is moving from experimental orthopedic analytics into commercial surgical workflow.

In May 2026, DePuy Synthes announced an agreement involving miniature radiofrequency tracking technology for joint reconstruction navigation and robotics. The intended technology could reduce reliance on optical line-of-sight tracking and potentially simplify future surgical workflows.

In July 2026, DePuy Synthes also acquired Expanding Innovations, adding expandable interbody cage technology to its spine portfolio. The transaction reflects continuing strategic interest in expandable implants, minimally invasive spine workflows, and differentiated lumbar fusion technologies.

Zimmer Biomet completed its acquisition of Monogram Technologies in October 2025. The transaction added AI-driven semi-autonomous and developing autonomous robotic technologies to Zimmer Biomet’s existing ROSA ecosystem and established a longer-term pathway toward higher levels of automation in orthopedic procedures.

Zimmer Biomet also received FDA clearance in November 2025 for ROSA Knee with OptimiZe, enhancing personalized surgical planning and intraoperative alignment capabilities. In May 2026, FDA records showed clearance of the ROSA Shoulder System, reinforcing the expansion of robotics beyond knee arthroplasty.

The competitive landscape is simultaneously undergoing portfolio restructuring. Johnson & Johnson announced in October 2025 its intention to separate the Orthopaedics business into a standalone DePuy Synthes company, highlighting the scale of orthopedic operations and the strategic importance of sharper portfolio focus.

These developments demonstrate that future competition will not be decided solely by which manufacturer produces the best implant. The market is moving toward an environment in which implant portfolios, robotics, AI, navigation, acquisitions, surgeon workflow, and site-of-care strategy operate as a single competitive system.

 

Conclusion

The U.S. Orthopedic Devices Market Size & Share is positioned for sustained expansion from approximately USD 32.80 billion in 2025 to USD 56.35 billion by 2035, representing an estimated 5.56% CAGR during 2026–2035.

The market is supported by powerful structural fundamentals. More than 53 million U.S. adults live with diagnosed arthritis, the population aged 65 and older has surpassed 61 million, approximately 10 million Americans have osteoporosis, millions more have low bone mass, and older-adult falls generate millions of medically significant injuries. At the same time, hip and knee replacement registries now contain millions of U.S. procedures, demonstrating the scale and maturity of reconstructive orthopedics.

Joint reconstruction will remain the market’s largest commercial foundation, but the composition of growth is changing. Premium expansion is increasingly concentrated in orthopedic robotics, cementless fixation, shoulder replacement, spine enabling technologies, foot and ankle reconstruction, advanced trauma systems, orthobiologics, patient-specific implants, 3D printing, navigation, and AI-enabled surgical planning.

The shift toward outpatient orthopedic surgery will be equally important. As more procedures migrate to hospital outpatient departments and ASCs, suppliers will need to redesign commercial offerings around procedure efficiency rather than hospital-era assumptions. Smaller equipment footprints, fewer instrument trays, predictable disposables, portable navigation, faster setup, efficient sterile processing, and capital flexibility will become important sources of competitive advantage.

Regional opportunity will remain concentrated in the South because of its population scale and demographic growth. Texas and Florida will be especially important, while North Carolina, Georgia, Tennessee, and Virginia provide additional expansion opportunities. The West is expected to deliver the fastest percentage growth through the forecast period, driven by California’s technology-intensive provider environment and population expansion across Arizona, Nevada, Utah, Colorado, and Idaho. The Northeast will remain an important premium-technology and academic market, while the Midwest will provide durable demand supported by established orthopedic care infrastructure and the industry’s manufacturing base.

For hospitals and health systems, the central purchasing question is shifting from “Which implant costs less?” to “Which orthopedic platform delivers the best combination of outcomes, operating-room efficiency, surgeon adoption, site-of-care flexibility, and total episode economics?”

For manufacturers, the market is becoming equally clear. Companies that depend primarily on mature implants face increasing commoditization and contracting pressure. Companies that surround strong implants with robotics, navigation, personalized planning, differentiated biomaterials, efficient instrumentation, clinical evidence, and ASC-compatible workflows will be better positioned to capture premium growth.

For investors, strategy teams, procurement leaders, and companies considering market entry, the most valuable opportunities through 2035 are likely to occur where four forces intersect: high procedure volume, measurable unmet clinical need, workflow improvement, and favorable healthcare economics. That intersection will define the next decade of the U.S. orthopedic devices industry.

 

TABLE OF CONTENT

1. U.S. Orthopedic Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Device and Implant Manufacturers
1.6.2. Biomaterial, Component and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Orthopedic Specialty Hospitals and Musculoskeletal Centers
1.6.5. Ambulatory Surgery Centers
1.6.6. Orthopedic Surgeons, Physician Groups and Specialty Practices
1.6.7. Group Purchasing Organizations and Distributors
1.6.8. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the U.S. orthopedic devices market boundary, study scope, methodology, assumptions, and stakeholder ecosystem, helping clients understand how joint reconstruction, spine, trauma, sports medicine, orthobiologics, and enabling technologies are measured and validated.

2. U.S. Orthopedic Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. Robotic-Assisted Joint Replacement
2.7.2. Cementless Hip and Knee Reconstruction
2.7.3. Minimally Invasive Spine Surgery
2.7.4. Shoulder and Extremity Reconstruction
2.7.5. ASC-Based Orthopedic Procedures
2.7.6. Patient-Specific and 3D-Printed Implants
2.7.7. AI-Assisted Surgical Planning and Navigation

What this section provides: This section gives decision-makers a concise view of market size, growth direction, procedure demand, technology adoption, competitive intensity, and priority opportunities across the U.S. orthopedic device ecosystem.

3. U.S. Orthopedic Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Osteoarthritis and Degenerative Joint Disease Burden
3.1.2. Aging U.S. Population and Growing Joint Replacement Demand
3.1.3. Increasing Hip and Knee Arthroplasty Procedure Volumes
3.1.4. Expanding Spine Surgery and Degenerative Spine Disease Burden
3.1.5. Increasing Trauma and Fragility Fracture Incidence
3.1.6. Growth of Orthopedic Procedures in Ambulatory Surgery Centers
3.1.7. Adoption of Robotic-Assisted Orthopedic Surgery
3.1.8. Expansion of Sports Medicine and Extremity Reconstruction
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant and Procedure Costs
3.2.2. Hospital Implant Price Standardization Pressure
3.2.3. Reimbursement and Bundled-Payment Constraints
3.2.4. Implant Recall, Revision and Product Liability Risk
3.2.5. Orthopedic Surgeon and Skilled Workforce Constraints
3.2.6. Capital Cost of Robotics and Navigation Platforms
3.3. Opportunities and Their Impact Analysis
3.3.1. Robotic-Assisted Total Knee and Hip Arthroplasty
3.3.2. Cementless and Advanced Fixation Technologies
3.3.3. Outpatient Joint Replacement and ASC Migration
3.3.4. AI-Enabled Orthopedic Surgical Planning
3.3.5. 3D-Printed and Patient-Specific Orthopedic Implants
3.3.6. Orthobiologics and Regenerative Technologies
3.3.7. Shoulder, Foot & Ankle and Extremity Reconstruction
3.3.8. Minimally Invasive and Robotic Spine Surgery
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Orthopedic Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Implant Standardization and Surgeon Preference Analysis
3.9. ASC Procedure Migration and Site-of-Care Economics

What this section provides: This section explains the clinical, demographic, economic, reimbursement, technological, and operational forces shaping orthopedic device demand and helps clients evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Orthopedic Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Orthopedic Implant Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Orthopedic Surgery
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Bundled Payments and Value-Based Orthopedic Care
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Musculoskeletal Health Programs
4.12. Impact of Escalating Geopolitical Tensions
4.13. Hospital Value Analysis Committee Decision Framework
4.14. Implant Vendor Consolidation and Contracting Trends
4.15. Physician Preference Item Procurement Dynamics

What this section provides: This section gives clients a complete view of regulation, reimbursement, implant pricing, supply-chain economics, technological change, value-based care, hospital contracting, and external factors influencing the U.S. orthopedic devices industry.

5. U.S. Orthopedic Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.2. Joint Reconstruction Devices
5.2.1. Knee Reconstruction Devices
5.2.1.1. Total Knee Replacement Systems
5.2.1.2. Partial Knee Replacement Systems
5.2.1.3. Revision Knee Systems
5.2.1.4. Cemented Knee Implants
5.2.1.5. Cementless Knee Implants
5.2.2. Hip Reconstruction Devices
5.2.2.1. Total Hip Replacement Systems
5.2.2.2. Femoral Components
5.2.2.3. Acetabular Components
5.2.2.4. Dual-Mobility Systems
5.2.2.5. Revision Hip Systems
5.2.3. Shoulder Reconstruction Devices
5.2.3.1. Anatomic Shoulder Systems
5.2.3.2. Reverse Shoulder Systems
5.2.3.3. Shoulder Revision Systems
5.3. Spinal Devices
5.3.1. Thoracolumbar Fixation Systems
5.3.2. Cervical Fixation Systems
5.3.3. Interbody Fusion Devices
5.3.4. Expandable Interbody Cages
5.3.5. Artificial Disc Replacement Devices
5.3.6. Minimally Invasive Spine Systems
5.3.7. Sacroiliac Joint Fixation Devices
5.4. Trauma & Extremity Devices
5.4.1. Plates and Screws
5.4.2. Intramedullary Nails
5.4.3. External Fixation Systems
5.4.4. Hand & Wrist Devices
5.4.5. Foot & Ankle Devices
5.4.6. Small Joint Reconstruction Devices
5.5. Sports Medicine & Arthroscopy Devices
5.5.1. Suture Anchors
5.5.2. Soft-Tissue Fixation Devices
5.5.3. Meniscal Repair Systems
5.5.4. Ligament Reconstruction Devices
5.5.5. Arthroscopy Visualization Systems
5.5.6. Shavers and RF Ablation Systems
5.5.7. Fluid Management Systems
5.6. Orthobiologics & Regenerative Products
5.6.1. Bone Graft Substitutes
5.6.2. Demineralized Bone Matrix
5.6.3. Synthetic Bone Grafts
5.6.4. Cellular Bone Matrices
5.6.5. Bone Growth Stimulation Products

What this section provides: This section identifies orthopedic device categories expected to generate the largest revenue contribution and highlights the subsegments positioned for stronger growth through 2035.

6. U.S. Orthopedic Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.2. Knee Reconstruction
6.2.1. Primary Total Knee Arthroplasty
6.2.2. Partial Knee Arthroplasty
6.2.3. Revision Knee Arthroplasty
6.3. Hip Reconstruction
6.3.1. Primary Total Hip Arthroplasty
6.3.2. Hip Fracture Reconstruction
6.3.3. Revision Hip Arthroplasty
6.4. Spine Surgery
6.4.1. Degenerative Spine Disease
6.4.2. Spinal Stenosis
6.4.3. Spinal Deformity
6.4.4. Cervical Disorders
6.4.5. Spinal Trauma
6.4.6. Sacroiliac Joint Disorders
6.5. Trauma & Fracture Management
6.5.1. Upper Extremity Trauma
6.5.2. Lower Extremity Trauma
6.5.3. Hip and Pelvic Fractures
6.5.4. Osteoporotic and Fragility Fractures
6.6. Shoulder, Sports Medicine & Extremity Reconstruction
6.6.1. Shoulder Arthroplasty
6.6.2. Rotator Cuff Repair
6.6.3. ACL/PCL Reconstruction
6.6.4. Meniscal Repair
6.6.5. Foot & Ankle Reconstruction
6.6.6. Hand & Wrist Reconstruction

What this section provides: This section helps clients understand orthopedic device demand by clinical use case and identify applications with attractive procedure growth, technology adoption, reimbursement relevance, and long-term implant opportunity.

7. U.S. Orthopedic Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.2. Hospitals and Integrated Health Systems
7.2.1. Large Tertiary Hospitals
7.2.2. Community Hospitals
7.2.3. Integrated Delivery Networks
7.3. Ambulatory Surgery Centers
7.3.1. Hospital-Owned ASCs
7.3.2. Physician-Owned ASCs
7.3.3. Independent Multispecialty ASCs
7.4. Orthopedic Specialty Hospitals & Musculoskeletal Centers
7.5. Orthopedic Clinics and Physician Practices
7.6. Trauma Centers & Academic Medical Centers

What this section provides: This section explains which U.S. care settings are expected to drive implant purchasing, orthopedic procedure volumes, robotic adoption, outpatient migration, and vendor contracting through 2035.

8. U.S. Orthopedic Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.2. Conventional Implant Systems
8.2.1. Metallic Implant Systems
8.2.2. Polymer-Based Implant Systems
8.2.3. Ceramic Implant Components
8.2.4. Cemented Fixation Systems
8.2.5. Cementless Fixation Systems
8.3. Robotic-Assisted Surgery Systems
8.3.1. Robotic Total Knee Systems
8.3.2. Robotic Hip Systems
8.3.3. Robotic Spine Systems
8.3.4. Robotic Shoulder Systems
8.3.5. Handheld and Compact Robotic Platforms
8.4. Navigation & Digital Surgery Technologies
8.4.1. CT-Based Navigation
8.4.2. Imageless Navigation
8.4.3. Optical Tracking Systems
8.4.4. AI-Assisted Surgical Planning
8.4.5. Smart Instruments and Intraoperative Analytics
8.5. 3D-Printed & Patient-Specific Technologies
8.5.1. 3D-Printed Joint Implants
8.5.2. 3D-Printed Spinal Implants
8.5.3. Patient-Specific Implants
8.5.4. Patient-Specific Surgical Guides
8.6. Advanced Biomaterials & Biologic Technologies
8.6.1. Porous Titanium Technologies
8.6.2. Advanced Polyethylene
8.6.3. Ceramic Technologies
8.6.4. Bioactive Coatings
8.6.5. Bone Graft and Regenerative Technologies

What this section provides: This section evaluates the technologies reshaping orthopedic care, including conventional implants, robotics, navigation, AI, additive manufacturing, patient-specific reconstruction, and advanced biomaterials.

9. U.S. Orthopedic Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.2. Direct Hospital and Health System Procurement
9.3. Integrated Delivery Network Enterprise Contracts
9.4. Group Purchasing Organization Contracts
9.5. Distributor and Specialty Supplier Sales
9.6. Ambulatory Surgery Center Procurement
9.7. Physician Preference Item and Surgeon-Led Procurement
9.8. Capital Equipment Leasing and Placement Agreements

What this section provides: This section explains how orthopedic implants, instruments, robotics, navigation systems, and biologics are purchased in the U.S., including IDN standardization, GPO contracting, surgeon influence, ASC procurement, and capital-placement models.

10. U.S. Orthopedic Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic Procedure Volume and Hospital Infrastructure Analysis
10.1.4. Regional Joint Replacement and Spine Surgery Demand Analysis
10.1.5. Regional ASC Penetration and Site-of-Care Migration
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Orthopedic Robotics Adoption Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states, helping clients identify orthopedic procedure hubs, aging-population demand centers, ASC expansion markets, robotics adoption hotspots, implant procurement patterns, and priority commercial opportunities.

11. U.S. Orthopedic Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Stryker Corporation
11.3.2. Zimmer Biomet Holdings, Inc.
11.3.3. DePuy Synthes
11.3.4. Smith+Nephew
11.3.5. Medtronic
11.3.6. Globus Medical
11.3.7. Enovis Corporation
11.3.8. Arthrex, Inc.
11.3.9. CONMED Corporation
11.3.10. Integra LifeSciences
11.3.11. Orthofix Medical
11.3.12. B. Braun / Aesculap
11.3.13. MicroPort Orthopedics
11.3.14. Treace Medical Concepts
11.3.15. SI-BONE, Inc.
11.3.16. THINK Surgical
11.3.17. Exactech
11.3.18. Acumed
11.3.19. Highridge Medical
11.3.20. Life Spine
11.3.21. restor3d
11.3.22. Canary Medical
11.3.23. Bioventus
11.3.24. Anika Therapeutics
11.3.25. OSSIO

Note: Each company profile will include company overview, U.S. orthopedic device portfolio, joint/spine/trauma/sports medicine positioning as applicable, enabling-technology strategy, U.S. commercial footprint, financial positioning, product pipeline, FDA and regulatory updates, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, orthopedic robotics and digital-surgery strategies, product innovation direction, acquisition activity, and strategic intelligence on leading U.S. orthopedic device companies.

12. U.S. Orthopedic Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Robotic-Assisted Joint Replacement
12.2.2. AI-Assisted Orthopedic Surgical Planning
12.2.3. Autonomous and Semi-Autonomous Orthopedic Robotics
12.2.4. Patient-Specific and Personalized Implants
12.2.5. 3D-Printed Orthopedic Devices
12.2.6. Cementless and Biologic Fixation
12.2.7. Smart Orthopedic Implants and Sensor-Enabled Technologies
12.2.8. Navigation and Tracking Technologies
12.2.9. Regenerative Orthopedics and Advanced Biologics
12.3. Emerging Business Trends
12.3.1. ASC Migration of Joint Replacement
12.3.2. Implant Vendor Consolidation
12.3.3. Robotics-as-a-Service and Flexible Capital Models
12.3.4. Integrated Implant-Robotics Ecosystems
12.3.5. Orthopedic Data Platforms and Outcomes Analytics
12.3.6. Growth of Shoulder and Extremity Portfolios
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. High-Growth Product Opportunity Matrix
12.7. High-Growth State Opportunity Matrix

What this section provides: This section prepares clients for changes in orthopedic technology, care delivery, market structure, site-of-care economics, investment priorities, and adoption scenarios expected to influence the market through 2035.

13. U.S. Orthopedic Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Orthopedic Surgeons and Physician Groups
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Orthopedic Robotics Commercialization Strategy
13.11. ASC Market Entry and Contracting Strategy
13.12. State-Level Commercial Prioritization Strategy
13.13. M&A and Partnership Opportunity Assessment

What this section provides: This section converts market intelligence into actionable strategic guidance for implant manufacturers, enabling-technology companies, providers, investors, distributors, and new entrants focused on growth, portfolio positioning, channel expansion, procurement access, and competitive differentiation.

14. U.S. Orthopedic Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Projection Disclaimer
14.7. Company and Competitive Intelligence Disclaimer

What this section provides: This section clarifies the report’s scope limitations, data-use conditions, market-estimation boundaries, forecasting assumptions, third-party information considerations, and applicable legal limitations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Devices Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Devices Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Devices Market: Key Assumptions
TABLE 5: U.S. Orthopedic Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Orthopedic Devices Market: Stakeholder Analysis
TABLE 7: U.S. Orthopedic Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Orthopedic Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Orthopedic Devices Market: Market Attractiveness Index
TABLE 10: U.S. Orthopedic Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Orthopedic Devices Market: Base Year Market Positioning, 2025 (US$ Billion)
TABLE 12: U.S. Orthopedic Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Orthopedic Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Orthopedic Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Orthopedic Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Orthopedic Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Orthopedic Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Orthopedic Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Orthopedic Devices Market: Orthopedic Clinical Workflow Economics Matrix
TABLE 20: U.S. Orthopedic Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. Orthopedic Devices Market: Implant Standardization and Surgeon Preference Analysis
TABLE 22: U.S. Orthopedic Devices Market: ASC Procedure Migration and Site-of-Care Economics
TABLE 23: U.S. Orthopedic Devices Market: PESTEL Analysis
TABLE 24: U.S. Orthopedic Devices Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Orthopedic Devices Market: Orthopedic Implant Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Orthopedic Devices Market: Value Chain Analysis
TABLE 27: U.S. Orthopedic Devices Market: Supply Chain Analysis
TABLE 28: U.S. Orthopedic Devices Market: Digitalization and Connected Orthopedic Surgery Impact
TABLE 29: U.S. Orthopedic Devices Market: Application & Innovation Landscape
TABLE 30: U.S. Orthopedic Devices Market: FDA Regulatory Framework Analysis
TABLE 31: U.S. Orthopedic Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 32: U.S. Orthopedic Devices Market: Bundled Payments and Value-Based Orthopedic Care
TABLE 33: U.S. Orthopedic Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 34: U.S. Orthopedic Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 35: U.S. Orthopedic Devices Market: Geopolitical and Supply Risk Analysis
TABLE 36: U.S. Orthopedic Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 37: U.S. Orthopedic Devices Market: Implant Vendor Consolidation and Contracting Trends
TABLE 38: U.S. Orthopedic Devices Market: Product Category Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by Product Category
TABLE 40: U.S. Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 41: U.S. Orthopedic Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 42: U.S. Orthopedic Devices Market: Joint Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Orthopedic Devices Market: Spinal Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Orthopedic Devices Market: Trauma & Extremity Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Orthopedic Devices Market: Sports Medicine & Arthroscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Orthopedic Devices Market: Orthobiologics & Regenerative Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Orthopedic Devices Market: Application Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Application
TABLE 49: U.S. Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 50: U.S. Orthopedic Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 51: U.S. Orthopedic Devices Market: Knee Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Orthopedic Devices Market: Hip Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Orthopedic Devices Market: Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Orthopedic Devices Market: Trauma & Fracture Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Orthopedic Devices Market: Shoulder, Sports Medicine & Extremity Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Orthopedic Devices Market: End User Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by End User
TABLE 58: U.S. Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 59: U.S. Orthopedic Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 60: U.S. Orthopedic Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Orthopedic Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Orthopedic Devices Market: Orthopedic Specialty Hospitals & Musculoskeletal Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Orthopedic Devices Market: Orthopedic Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Orthopedic Devices Market: Trauma Centers & Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Orthopedic Devices Market: Technology Type Snapshot, 2025
TABLE 66: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 67: U.S. Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 68: U.S. Orthopedic Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 69: U.S. Orthopedic Devices Market: Conventional Implant Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Orthopedic Devices Market: Robotic-Assisted Surgery Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Orthopedic Devices Market: Navigation & Digital Surgery Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Orthopedic Devices Market: 3D-Printed & Patient-Specific Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Orthopedic Devices Market: Advanced Biomaterials & Biologic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Orthopedic Devices Market: Procurement Channel Snapshot, 2025
TABLE 75: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 76: U.S. Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 77: U.S. Orthopedic Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 78: U.S. Orthopedic Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Orthopedic Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Orthopedic Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Orthopedic Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Orthopedic Devices Market: Ambulatory Surgery Center Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Orthopedic Devices Market: Physician Preference Item and Surgeon-Led Procurement Analysis
TABLE 84: U.S. Orthopedic Devices Market: Capital Equipment Leasing and Placement Agreements
TABLE 85: U.S. Orthopedic Devices Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Geography
TABLE 87: U.S. Orthopedic Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Orthopedic Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: U.S. Orthopedic Devices Market: Regional Procedure Volume and Orthopedic Infrastructure Analysis
TABLE 90: U.S. Orthopedic Devices Market: Regional ASC Penetration and Robotics Adoption Analysis
TABLE 91: West Region U.S. Orthopedic Devices Market: Regional Overview and Trends
TABLE 92: West Region U.S. Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 99: California Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Washington Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Arizona Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Colorado Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Oregon Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Utah Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Nevada Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: New Mexico Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Idaho Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Montana Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Wyoming Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Alaska Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Hawaii Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Orthopedic Devices Market: Regional Overview and Trends
TABLE 113: Northeast Region U.S. Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 114: Northeast Region U.S. Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: New York Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Massachusetts Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: New Jersey Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Pennsylvania Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Connecticut Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Maine Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Vermont Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: New Hampshire Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Rhode Island Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Delaware Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Orthopedic Devices Market: Regional Overview and Trends
TABLE 131: South Region U.S. Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 132: South Region U.S. Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Texas Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Florida Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Georgia Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: North Carolina Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Tennessee Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: South Carolina Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Alabama Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Mississippi Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Louisiana Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Arkansas Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Kentucky Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Oklahoma Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Virginia Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Maryland Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: West Virginia Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Midwest Region U.S. Orthopedic Devices Market: Regional Overview and Trends
TABLE 154: Midwest Region U.S. Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 155: Midwest Region U.S. Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 161: Illinois Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Ohio Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Michigan Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Minnesota Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Indiana Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Wisconsin Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Missouri Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Iowa Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Kansas Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Nebraska Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: North Dakota Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: South Dakota Orthopedic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: U.S. Orthopedic Devices Market: Competitive Landscape Snapshot, 2025
TABLE 174: U.S. Orthopedic Devices Market: Key Company Market Share Analysis, 2025
TABLE 175: U.S. Orthopedic Devices Market: Company Positioning Matrix
TABLE 176: U.S. Orthopedic Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 177: U.S. Orthopedic Devices Market: Robotics and Digital Surgery Competitive Benchmarking
TABLE 178: U.S. Orthopedic Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 179: Stryker Corporation: Company Profile
TABLE 180: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 181: DePuy Synthes: Company Profile
TABLE 182: Smith+Nephew: Company Profile
TABLE 183: Medtronic: Company Profile
TABLE 184: Globus Medical: Company Profile
TABLE 185: Enovis Corporation: Company Profile
TABLE 186: Arthrex, Inc.: Company Profile
TABLE 187: CONMED Corporation: Company Profile
TABLE 188: Integra LifeSciences: Company Profile
TABLE 189: Orthofix Medical: Company Profile
TABLE 190: B. Braun / Aesculap: Company Profile
TABLE 191: MicroPort Orthopedics: Company Profile
TABLE 192: Treace Medical Concepts: Company Profile
TABLE 193: SI-BONE, Inc.: Company Profile
TABLE 194: THINK Surgical: Company Profile
TABLE 195: Exactech: Company Profile
TABLE 196: Acumed: Company Profile
TABLE 197: Highridge Medical: Company Profile
TABLE 198: Life Spine: Company Profile
TABLE 199: restor3d: Company Profile
TABLE 200: Canary Medical: Company Profile
TABLE 201: Bioventus: Company Profile
TABLE 202: Anika Therapeutics: Company Profile
TABLE 203: OSSIO: Company Profile
TABLE 204: U.S. Orthopedic Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 205: U.S. Orthopedic Devices Market: Disruptive Technologies Impact Matrix
TABLE 206: U.S. Orthopedic Devices Market: Orthopedic Robotics Opportunity Assessment
TABLE 207: U.S. Orthopedic Devices Market: AI-Assisted Surgical Planning Opportunity Assessment
TABLE 208: U.S. Orthopedic Devices Market: Patient-Specific and 3D-Printed Implant Opportunity Assessment
TABLE 209: U.S. Orthopedic Devices Market: Emerging Business Trends
TABLE 210: U.S. Orthopedic Devices Market: Business Opportunities for Startups and Existing Players
TABLE 211: U.S. Orthopedic Devices Market: Investment Prioritization Matrix
TABLE 212: U.S. Orthopedic Devices Market: High-Growth Product Opportunity Matrix
TABLE 213: U.S. Orthopedic Devices Market: High-Growth State Opportunity Matrix
TABLE 214: U.S. Orthopedic Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 215: U.S. Orthopedic Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 216: U.S. Orthopedic Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 217: U.S. Orthopedic Devices Market: Strategic Recommendations for Orthopedic Surgeons and Physician Groups
TABLE 218: U.S. Orthopedic Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 219: U.S. Orthopedic Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 220: U.S. Orthopedic Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 221: U.S. Orthopedic Devices Market: Go-to-Market Strategy Considerations
TABLE 222: U.S. Orthopedic Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 223: U.S. Orthopedic Devices Market: Orthopedic Robotics Commercialization Strategy
TABLE 224: U.S. Orthopedic Devices Market: ASC Market Entry and Contracting Strategy
TABLE 225: U.S. Orthopedic Devices Market: State-Level Commercial Prioritization Strategy
TABLE 226: U.S. Orthopedic Devices Market: M&A and Partnership Opportunity Assessment
TABLE 227: U.S. Orthopedic Devices Market: Scope Limitation
TABLE 228: U.S. Orthopedic Devices Market: Data Use Limitation
TABLE 229: U.S. Orthopedic Devices Market: Forecasting Limitation
TABLE 230: U.S. Orthopedic Devices Market: Legal Disclaimer
TABLE 231: U.S. Orthopedic Devices Market: Third-Party Data Disclaimer
TABLE 232: U.S. Orthopedic Devices Market: Market Estimation and Projection Disclaimer
TABLE 233: U.S. Orthopedic Devices Market: Company and Competitive Intelligence Disclaimer

List of Figures

FIGURE 1: U.S. Orthopedic Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Orthopedic Devices Market Ecosystem
FIGURE 4: U.S. Orthopedic Devices Market Stakeholder Framework
FIGURE 5: U.S. Orthopedic Devices Market Executive Snapshot, 2025
FIGURE 6: U.S. Orthopedic Devices Market Attractiveness Analysis
FIGURE 7: U.S. Orthopedic Devices Market Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 8: U.S. Orthopedic Devices Market Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 9: U.S. Orthopedic Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 10: U.S. Orthopedic Devices Market High-Growth Opportunity Map
FIGURE 11: U.S. Orthopedic Devices Market Dynamics
FIGURE 12: Orthopedic Innovation & Patent Landscape, 2021–2025
FIGURE 13: Orthopedic Clinical Workflow Economics Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: Implant Standardization and Surgeon Preference Framework
FIGURE 16: ASC Procedure Migration and Site-of-Care Economics Framework
FIGURE 17: PESTEL Analysis
FIGURE 18: Porter’s Five Forces Analysis
FIGURE 19: Orthopedic Implant Pricing Trend, 2025–2035
FIGURE 20: Value Chain Analysis
FIGURE 21: Supply Chain Analysis
FIGURE 22: Digital Orthopedic Surgery Innovation Landscape
FIGURE 23: FDA Regulatory and CMS Reimbursement Framework
FIGURE 24: Hospital Value Analysis Committee Decision Framework
FIGURE 25: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Product Category Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Joint Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Spinal Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Trauma & Extremity Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Sports Medicine & Arthroscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Orthobiologics & Regenerative Products Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Knee Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Hip Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Spine Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Trauma & Fracture Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Shoulder, Sports Medicine & Extremity Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 40: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Orthopedic Specialty Hospitals & Musculoskeletal Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Orthopedic Clinics and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Trauma Centers & Academic Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Conventional Implant Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Robotic-Assisted Surgery Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Navigation & Digital Surgery Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: 3D-Printed & Patient-Specific Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Advanced Biomaterials & Biologic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Ambulatory Surgery Center Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Physician Preference Item and Surgeon-Led Procurement Framework
FIGURE 61: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 62: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: U.S. Orthopedic Procedure Volume and Infrastructure Opportunity Map
FIGURE 64: U.S. ASC Penetration and Orthopedic Robotics Adoption Map
FIGURE 65: West Region U.S. Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 66: West Region Market Share Analysis by State, 2025
FIGURE 67: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: California Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Washington Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Arizona Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Colorado Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Oregon Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Utah Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Nevada Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New Mexico Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Idaho Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Montana Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Wyoming Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Alaska Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Hawaii Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Northeast Region U.S. Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 82: Northeast Region Market Share Analysis by State, 2025
FIGURE 83: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: New York Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Massachusetts Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: New Jersey Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Pennsylvania Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Connecticut Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Maine Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Vermont Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: New Hampshire Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Rhode Island Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Delaware Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: South Region U.S. Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 95: South Region Market Share Analysis by State, 2025
FIGURE 96: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Texas Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Florida Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Georgia Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: North Carolina Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Tennessee Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: South Carolina Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Alabama Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Mississippi Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Louisiana Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Arkansas Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Kentucky Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Oklahoma Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Virginia Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Maryland Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: West Virginia Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Midwest Region U.S. Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 113: Midwest Region Market Share Analysis by State, 2025
FIGURE 114: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Illinois Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Ohio Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Michigan Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Minnesota Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Indiana Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Wisconsin Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Missouri Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Iowa Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Kansas Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Nebraska Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 125: North Dakota Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 126: South Dakota Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 127: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 128: Company Positioning Matrix
FIGURE 129: Key Player Product Portfolio Benchmarking
FIGURE 130: Orthopedic Robotics and Digital Surgery Competitive Benchmarking
FIGURE 131: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 132: U.S. Orthopedic Device Innovation Roadmap
FIGURE 133: Future Market Scenario Analysis, 2026–2035
FIGURE 134: Disruptive Technologies Impact Matrix
FIGURE 135: Robotic-Assisted Orthopedic Surgery Adoption Roadmap
FIGURE 136: AI-Assisted Surgical Planning Opportunity Map
FIGURE 137: Patient-Specific and 3D-Printed Implant Opportunity Map
FIGURE 138: Smart Implant and Sensor-Enabled Orthopedics Roadmap
FIGURE 139: Emerging Business Trends Matrix
FIGURE 140: Investment Prioritization Matrix
FIGURE 141: High-Growth Product Opportunity Matrix
FIGURE 142: High-Growth State Opportunity Map
FIGURE 143: Strategic Growth Roadmap for U.S. Orthopedic Device Companies
FIGURE 144: ASC Market Entry and Contracting Framework
FIGURE 145: Orthopedic Robotics Commercialization Framework
FIGURE 146: Go-to-Market Strategy Framework
FIGURE 147: Product Positioning and Portfolio Expansion Framework
FIGURE 148: M&A and Partnership Opportunity Framework
FIGURE 149: Report Scope and Disclaimer Framework